These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6518323

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K, McElroy PD, Jereb J, Navin TR, Castro KG.
    Clin Infect Dis; 2007 Feb 01; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S, Armas Merino R, Busel I, Baier E, Wolff C, Jabsa Z.
    Rev Med Chil; 1981 Mar 01; 109(3):212-20. PubMed ID: 7280406
    [No Abstract] [Full Text] [Related]

  • 26. [Side effects of antitubercular drugs in patients with pulmonary tuberculosis and chronic alcoholism].
    Rudoĭ NM, Chubakov TCh.
    Sov Med; 1984 Mar 01; (8):7-10. PubMed ID: 6494999
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C, Nicopoulos C, Vassiliou M, Manda-Stachouli C, Sakellariou K, Demou GS, Constantopoulos SH.
    Int J Tuberc Lung Dis; 1998 Aug 01; 2(8):675-8. PubMed ID: 9712283
    [Abstract] [Full Text] [Related]

  • 29. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W, Lindemann I.
    Z Erkr Atmungsorgane Folia Bronchol; 1969 Aug 01; 131(1):87-98. PubMed ID: 5197904
    [No Abstract] [Full Text] [Related]

  • 30. [Pyrogenic agents in the therapy of pulmonary tuberculosis patients suffering from alcoholism].
    Kalabukha VA, Kalabukha AV.
    Probl Tuberk; 1985 Aug 01; (4):38-41. PubMed ID: 4001107
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ, Fatima N, ul Haque E, Shiekh AS, Bhatti MS.
    J Ayub Med Coll Abbottabad; 2001 Aug 01; 13(2):5-10. PubMed ID: 11732224
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V, Klapálek D, Paichl P, Pecený A.
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct 01; 25(4):250-2. PubMed ID: 5888913
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.